ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California and currently employs 25 full-time employees. The firm provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The firm markets and sells its medical device products through independent distributors.
Follow-Up Questions
Thermogenesis Holdings Inc (THMO)'in P/E oranı nedir?
Thermogenesis Holdings Inc 'in P/E oranı 0 'dir
Thermogenesis Holdings Inc 'in CEO'su kimdir?
Dr. Xiaochun Xu 2016 'den beri şirketle birlikte olan Thermogenesis Holdings Inc 'in Chairman of the Board 'ıdır.
THMO hissesinin fiyat performansı nasıl?
THMO 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
Thermogenesis Holdings Inc için ana iş temaları veya sektörler nelerdir?
Thermogenesis Holdings Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Wall Street analistlerine göre, 3 analist Thermogenesis Holdings Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 4 al, 1 tut, 0 sat ve 2 güçlü sat içermektedir
